Showing results (81-90 of 257) with videos related to

Sort By:
Pageof 26
Cancer Medicine|April 23, 2020
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Odoardo Olimpieri, et al.
Annals of Hematology|January 21, 2025
Spleen volume assessment in Ph-negative chronic myeloproliferative neoplasms: a real-life study comparing ultrasonography vs. magnetic resonance imaging scansNovella Pugliese, Carlo Cavaliere, Luca Basso, et al.
International Journal of Molecular Sciences|June 10, 2023
Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable DiseaseValentina Rubino, Flavia Carriero, Anna Teresa Palatucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphomaMarco Picardi, Nicola Gennarelli, Rosanna Ciancia, et al.
Oncotarget|August 31, 2015
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogeneGiorgia Montano, Karina Vidovic, Chiara Palladino, et al.
Haematologica|July 5, 2006
Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective studyMarco Picardi, Rosanna Ciancia, Amalia De Renzo, et al.
Cancer Medicine|March 11, 2020
Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paperSimona Soverini, Francesco Albano, Renato Bassan, et al.
Annals of Hematology|September 20, 2025
Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registriesMassimo Breccia, Simone Celant, Francesca Palandri, et al.
Haematologica|February 13, 2008
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemiaBrunangelo Falini, Cristina Mecucci, Giuseppe Saglio, et al.
Cancer Medicine|May 31, 2017
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemiaNovella Pugliese, Paola Salvatore, Dora Vita Iula, et al.
Pageof 26